|
1
|
Shi J, Sun B, Shi W, Zuo H, Cui D, Ni L
and Chen J: Decreasing GSH and increasing ROS in chemosensitivity
gliomas with IDH1 mutation. Tumour Biol. 36:655–662. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baldock AL, Ahn S, Rockne R, Johnston S,
Neal M, Corwin D, Clark-Swanson K, Sterin G, Trister AD, Malone H,
et al: Patient-specific metrics of invasiveness reveal significant
prognostic benefit of resection in a predictable subset of gliomas.
PLoS One. 9:e990572014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bellail AC, Hunter SB, Brat DJ, Tan C and
Van Meir EG: Microregional extracellular matrix heterogeneity in
brain modulates glioma cell invasion. Int J Biochem Cell Biol.
36:1046–1069. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang M, Yoshida D, Liu S and Teramoto A:
Inhibition of cell invasion by indomethacin on glioma cell lines:
In vitro study. J Neurooncol. 72:1–9. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jacob A and Prekeris R: The regulation of
MMP targeting to invadopodia during cancer metastasis. Front Cell
Dev Biol. 3:42015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rao JS: Molecular mechanisms of glioma
invasiveness: The role of proteases. Nat Rev Cancer. 3:489–501.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alam S and Kelleher SL: Cellular
mechanisms of zinc dysregulation: A perspective on zinc homeostasis
as an etiological factor in the development and progression of
breast cancer. Nutrients. 4:875–903. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tian L, Zhang Y, Chen Y, Cai M, Dong H and
Xiong L: EMMPRIN is an independent negative prognostic factor for
patients with astrocytic glioma. PLoS One. 8:e580692013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee EJ, Kim SY, Hyun JW, Min SW, Kim DH
and Kim HS: Glycitein inhibits glioma cell invasion through
down-regulation of MMP-3 and MMP-9 gene expression. Chem Biol
Interact. 185:18–24. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Levicar N, Nuttall RK and Lah TT:
Proteases in brain tumour progression. Acta Neurochir (Wien).
145:825–838. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Alcantara MB and Dass CR: Pigment
epithelium-derived factor as a natural matrix metalloproteinase
inhibitor: A comparison with classical matrix metalloproteinase
inhibitors used for cancer treatment. J Pharm Pharmacol.
66:895–902. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hadler-Olsen E, Winberg JO and
Uhlin-Hansen L: Matrix metalloproteinases in cancer: Their value as
diagnostic and prognostic markers and therapeutic targets. Tumour
Biol. 34:2041–2051. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh D, Srivastava SK, Chaudhuri TK and
Upadhyay G: Multifaceted role of matrix metalloproteinases (MMPs).
Front Mol Biosci. 2:192015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoshizaki T, Sato H and Furukawa M: Recent
advances in the regulation of matrix metalloproteinase 2
activation: From basic research to clinical implication (Review).
Oncol Rep. 9:607–611. 2002.PubMed/NCBI
|
|
15
|
Dufour A and Overall CM: Missing the
target: Matrix metalloproteinase antitargets in inflammation and
cancer. Trends Pharmacol Sci. 34:233–242. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vandenbroucke RE and Libert C: Is there
new hope for therapeutic matrix metalloproteinase inhibition? Nat
Rev Drug Discov. 13:904–927. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu RH: Health-promoting components of
fruits and vegetables in the diet. Adv Nutr. 4:384S–392S. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park WH, Kim SH and Kim CH: A new matrix
metalloproteinase-9 inhibitor 3,4-dihydroxycinnamic acid (caffeic
acid) from methanol extract of Euonymus alatus: Isolation and
structure determination. Toxicology. 207:383–390. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chiang EP, Tsai SY, Kuo YH, Pai MH, Chiu
HL, Rodriguez RL and Tang FY: Caffeic acid derivatives inhibit the
growth of colon cancer: Involvement of the PI3-K/Akt and AMPK
signaling pathways. PLoS One. 9:e996312014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ozturk G, Ginis Z, Akyol S, Erden G, Gurel
A and Akyol O: The anticancer mechanism of caffeic acid phenethyl
ester (CAPE): Review of melanomas, lung and prostate cancers. Eur
Rev Med Pharmacol Sci. 16:2064–2068. 2012.PubMed/NCBI
|
|
21
|
Chung TW, Moon SK, Chang YC, Ko JH, Lee
YC, Cho G, Kim SH, Kim JG and Kim CH: Novel and therapeutic effect
of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma
cells: Complete regression of hepatoma growth and metastasis by
dual mechanism. FASEB J. 18:1670–1681. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li
W, Yin L, Yang JP and Duan JA: Synthesis and structure-activity
relationship analysis of caffeic acid amides as selective matrix
metalloproteinase inhibitors. Bioorg Med Chem Lett. 23:1206–1211.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Villano JL, Seery TE and Bressler LR:
Temozolomide in malignant gliomas: Current use and future targets.
Cancer Chemother Pharmacol. 64:647–655. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wait SD, Prabhu RS, Burri SH, Atkins TG
and Asher AL: Polymeric drug delivery for the treatment of
glioblastoma. Neuro Oncol. 17:(Suppl 2). ii9–ii23. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Davies KJ: The complex Interaction of
matrix metalloproteinases in the migration of cancer cells through
breast tissue stroma. Int J Breast Cancer. 2014:8390942014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Könnecke H and Bechmann I: The role of
microglia and matrix metalloproteinases involvement in
neuroinflammation and gliomas. Clin Dev Immunol. 2013:9141042013.
View Article : Google Scholar : PubMed/NCBI
|
